What is Azithromycin?
Azithromycin is a class of drugs, belongs to antibacterials antibiotics. It is an antibiotic that helps treat bacterial infections. It is commonly sold under the brand names Zithromax and Zmax. A doctor may prescribe azithromycin to treat mild-to-moderate infections of the lungs, sinuses, skin, and other body parts. It can resist harmful bacteria from growing and is able to fight a wide range of bacteria, including many in the streptococcus family.
Global Azithromycin Market Outlook
The increasing prevalence of bacterial infection is driving the growth of azithromycin market. Azithromycin is a world best-selling antibiotic. It is proved to be extremely efficient and capable of remaining in the body tissue longer than another similar alternative. Companies are investing and investigating significantly in azithromycin market for a new treatment, opening the way to new markets. For instance, FDA approval for preventing bacterial infections in people with HIV. But at the same time, FDA disapproval for several therapies due to risk factor associated is restraining the growth of azithromycin market.
At present, azithromycin is approved for acute bacterial urethritis, genital ulcer disease, sinusitis, bacterial exacerbations of chronic obstructive pulmonary disease community-acquired pneumonia, pharyngitis, skin infections and among other conditions.
Global Azithromycin Market Competitive Landscape
The "Global Azithromycin Market" study report will provide a valuable insight with an emphasis on global market including some of the major players such Pfizer, Pliva, Betterway Pharm, CNCM and North China Pharmaceuticals. Our market analysis also entails a section solely dedicated for such major players wherein our analysts provide an insight to the financial statements of all the major players, along with its product benchmarking and SWOT analysis.
Customization of the Report
• In case of any queries or customization requirements please connect with our sales team, who will ensure that your requirements are met.
1. INTRODUCTION OF GLOBAL AZITHROMYCIN MARKET
1.1. Overview of the Market
1.2. Scope of Report
1.3. Assumptions
2. EXECUTIVE SUMMARY
3. RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH
3.1. Data Mining
3.2. Validation
3.3. Primary Interviews
3.4. List of Data Sources
4. GLOBAL AZITHROMYCIN MARKET OUTLOOK
4.1. Overview
4.2. Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.3. Porters Five Force Model
4.4. Value Chain Analysis
5. GLOBAL AZITHROMYCIN MARKET, BY TYPE
5.1. Overview
5.2. Oral
5.3. Injectable
5.4. Ophthalmic
6. GLOBAL AZITHROMYCIN MARKET, BY DISTRIBUTION CHANNEL
6.1. Overview
6.2. Hospital Pharmacies
6.3. Retail Pharmacies
6.4. Online Pharmacies
7. GLOBAL AZITHROMYCIN MARKET, BY GEOGRAPHY
7.1. Overview
7.2. North America
7.2.1. U.S.
7.2.2. Canada
7.2.3. Mexico
7.3. Europe
7.3.1. Germany
7.3.2. U.K.
7.3.3. France
7.3.4. Rest of Europe
7.4. Asia Pacific
7.4.1. China
7.4.2. Japan
7.4.3. India
7.4.4. Rest of Asia Pacific
7.5. Rest of the World
7.5.1. Latin America
7.5.2. Middle East & Africa
8. GLOBAL AZITHROMYCIN MARKET COMPETITIVE LANDSCAPE
8.1. Overview
8.2. Company Market Ranking
8.3. Key Development Strategies
9. COMPANY PROFILES
9.1. Pfizer
10.1.1 Overview
10.1.2 Financial Performance
10.1.3 Product Outlook
10.1.4 Key Developments
9.2. Pliva
9.2.1. Overview
9.2.2. Financial Performance
9.2.3. Product Outlook
9.2.4. Key Developments
9.3. Betterway Pharm
9.3.1. Overview
9.3.2. Financial Performance
9.3.3. Product Outlook
9.3.4. Key Developments
9.4. CNCM
9.4.1. Overview
9.4.2. Financial Performance
9.4.3. Product Outlook
9.4.4. Key Developments
9.5. North China Pharmaceuticals
9.5.1. Overview
9.5.2. Financial Performance
9.5.3. Product Outlook
9.5.4. Key Developments
10. Appendix
10.1. Related Reports